Natco Pharma Ltd - (NATCOPHARM)

Incorporated in Sep.81 as Natco Fine Pharmaceutical Ltd, it became a deemed public company with effect from Jul.92 and in Feb.93, it changed its name to Natco Pharma (NPL). NPL began to manufacture conventional and time-release dosage forms of life-saving drugs. NPL is a contract manufacturer for reputed companies like Ranbaxy and Parke Davis. It has also obtained the coveted ISO 9002 certification, which will boost exports. It has initiated registration proceedings (for its formulations) in over 20 countries. To channelise its operations in the US, NPL has formed a new subsidiary, Natco Pharma, US. It has entered into research collaborations with Regional Research Laboratories, Jammu, for keto-L-gluconic acid (a penultimate for iso-ascorbic acid), with the Centre for Cellular & Molecular Biology for synthetic peptides and with the Central Leather Research Institute for oral vaccines. The company has introduced drugs like diltiazem, mononitrate, etc, in time-release form. Natco Laboratories, Natco Parenterals and Karanth Pharmaceuticals have merged with the flagship company, NPL to capitalise on the opportunities in the post-GATT era, to provide a large asset base and to increase high-technology capability. During 1995-96, NPL has implemented the project for formulations in the US. As a part of its diversification plans, the company is participating in the development of Krishnapatnam Industrial Port City Project, Nellore District, in collaboration with ITOCHU, Japan, Flour Daniels, USA, and HAM, Netherlands to create infrastructure. During 1996-97, the company entered into a agreement whereby Ranbaxy Laboratories (RLL) acquires rights in marketing certain NPLs products in Russia, Ukraine and other countries of CIS. Krishnapatnam Port Project has succeeded in signinig up with the UK based Indo British Port Development Consortium to develop the project. Natco is a minority participant in this project. The Andhra Pradesh government has extended the time allowed for time closure of Krishnapatnam Port project by another 2 years. The project is now proposed to be developed in 2 phases. In the first phase,it proposed to contrct 2 berths-one for loading and another for unloading. This facility is expected to be operational by August/September,2002 and thereafter,lighterage operations could commence.

see more see less

Key Statistics

1 Month Return
1 Year Return

News

See More

Key Executives

  • Tarun Khanna

    Alternate Director
  • PSRK Prasad

    Additional Director
  • MUR Naidu

    Additional Director
  • D Linga Rao

    Additional Director
  • G S Murthy

    Independent Director
  • B S Bajaj

    Independent Director
  • Rajeev Nannapaneni

    Vice Chairman & CEO
  • M Adinarayana

    Company Secretary
  • A K S Bhujanga Rao

    President
  • T V Rao

    Nominee (EXIM)
  • VIVEK CHHACHHI

    Additional Director
  • D G Prasad

    Additional Director
  • Leelaa Digumarti

    Additional Director
  • V C Nannapaneni

    Chairman & Managing Director
See More

Peer Company List

See More

Staks Containing NATCOPHARM

  • DEFENSIVE PHARMA

See More